Premium
Congenital mesoblastic nephroma 50 years after its recognition: A narrative review
Author(s) -
Gooskens S. L.,
Houwing M. E.,
Vujanic G. M.,
Dome J. S.,
Diertens T.,
Coulombl'Herminé A.,
Godzinski J.,
PritchardJones K.,
Graf N.,
HeuvelEibrink M. M.
Publication year - 2017
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26437
Subject(s) - medicine , narrative review , pediatrics , narrative , surgery , intensive care medicine , philosophy , linguistics
Congenital mesoblastic nephroma (CMN) is a rare pediatric renal tumor with low malignant potential that most commonly occurs early in infancy. Treatment strategies are based on the few published CMN series, while a significant number of CMN patients have been described in case reports. The aim of this narrative review was to create an up‐to‐date overview of the literature. Complete surgical removal is curative in most cases. The risk of treatment‐related mortality (both surgery‐ and chemotherapy‐related) is relatively high in the first weeks of life, indicating that these young patients deserve special attention with respect to timing and type of treatment.